134 related articles for article (PubMed ID: 9480565)
1. [Effect of opioids and gamma-aminobutyric acid on ovulation].
Spremović-Radjenović S; Popović V; Matijasević S; Lazović G; Petković S
Srp Arh Celok Lek; 1997; 125(11-12):329-32. PubMed ID: 9480565
[TBL] [Abstract][Full Text] [Related]
2. Effect of sodium valproate on luteinizing hormone secretion in pre- and postmenopausal women and its modulation by naloxone infusion.
Popovic V; Spremovic-Radjenovic S; Eric-Marinkovic J; Grossman A
J Clin Endocrinol Metab; 1996 Jul; 81(7):2520-4. PubMed ID: 8675571
[TBL] [Abstract][Full Text] [Related]
3. [Acute and chronic treatment with sodium valproate on gonadotropin hormone levels before menopause and during menopause].
Spremović-Radjenović S; Popović V; Matijasević S; Erić-Marinković J
Srp Arh Celok Lek; 1996; 124(7-8):179-83. PubMed ID: 9102843
[TBL] [Abstract][Full Text] [Related]
4. Influence of sodium valproate on medium-late luteal phase pulsatile LH secretion in normal women.
Lado Abeal J; Rey Losada C; Cabezas Agricola JM; Cabezas-Cerrato J
Clin Endocrinol (Oxf); 1994 Jan; 40(1):127-31. PubMed ID: 8306471
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
7. Opioidergic, dopaminergic and adrenergic regulation of LH secretion in prepubertal heifers.
Honaramooz A; Chandolia RK; Beard AP; Rawlings NC
J Reprod Fertil; 2000 Jul; 119(2):207-15. PubMed ID: 10864832
[TBL] [Abstract][Full Text] [Related]
8. Effects of valproate-induced alteration of the GABAergic system on pulsatile luteinizing hormone secretion in ovariectomized women.
Lado-Abeal J; Liz JL; Rey C; Febrero M; Cabezas-Cerrato J
Eur J Endocrinol; 1996 Sep; 135(3):293-8. PubMed ID: 8890719
[TBL] [Abstract][Full Text] [Related]
9. In pubertal girls, naloxone fails to reverse the suppression of luteinizing hormone secretion by estradiol.
Cemeroglu AP; Kletter GB; Guo W; Brown MB; Kelch RP; Marshall JC; Padmanabhan V; Foster CM
J Clin Endocrinol Metab; 1998 Oct; 83(10):3501-6. PubMed ID: 9768654
[TBL] [Abstract][Full Text] [Related]
10. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
11. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
[TBL] [Abstract][Full Text] [Related]
12. The role of endogenous opioids in the ovulatory LH surge in mares.
Alexander SL; Irvine CH; Shand N; Turner J
J Reprod Fertil Suppl; 2000; (56):217-26. PubMed ID: 20681133
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
14. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys.
Kletter GB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP; Foster CM
J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endogenous gabaergic system in the modulation of gonadotropin secretion in normal cycling women.
Melis GB; Mais V; Paoletti AM; Beneventi F; Petacchi FD; Fioretti P
J Endocrinol Invest; 1986 Feb; 9(1):71-6. PubMed ID: 3084617
[TBL] [Abstract][Full Text] [Related]
17. Prolonged opioid blockade does not influence luteinizing hormone modifications of the follicular and luteal menstrual phases.
Cagnacci A; Paoletti AM; Soldani R; Tuveri F; Melis GB
J Clin Endocrinol Metab; 1995 Mar; 80(3):860-3. PubMed ID: 7883843
[TBL] [Abstract][Full Text] [Related]
18. The effect of sodium valproate on luteinizing hormone secretion in women with polycystic ovary disease.
Popovic V; Spremovic S
J Endocrinol Invest; 1995 Feb; 18(2):104-8. PubMed ID: 7629374
[TBL] [Abstract][Full Text] [Related]
19. Interaction between gabaergic and opioid pathways in the regulation of gonadotropin secretion in males.
Elias AN; Kyaw T; Stone S; Weathersbee P; Iyer K; Ascher MS
Horm Metab Res; 1986 Dec; 18(12):838-41. PubMed ID: 3102338
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
